Omeprazole Market Trends

  • Report ID: 2477
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Omeprazole Market Trends

Growth Drivers

  • Increasing Cases of Gastroesophageal Reflux Omeprazole is a prescribed proton pump inhibitor (PPI) that aids in reducing acidity. Due to its effective results, this drug has been approved by regulatory agencies in order to cure heartburns as well as for the treatment of gastroesophageal reflux. Apart from the elderly population gastroesophageal reflux can affect youngsters as well which is boosting the growth of the omeprazole market. According to El-Serag et al.'s systematic review, gastroesophageal reflux prevalence in the US ranges from 18.1% to 27.8%.
  • Increasing Awareness among People- Increasing awareness among people for the treatment of gastrointestinal diseases is also expected to drive market growth. For example, the International Foundation for Functional Gastrointestinal Disorders, a not-for-profit educational and research organization, helps improve the lives of people with chronic digestive disorders. The IFFGD enhances knowledge, supports research, and improves the education of individuals.
  • Increasing prevalence of Duodenal Ulcers – An increasing number of patients who are suffering from peptic ulcers are in increased need of the treatment of the disease using the Omeprazole drug. Also, as per a report by Virtual Medical Centre, the most common disease in the world is peptic ulcer, around 10-15% of the population is affected globally. Men and the elderly population generally suffer from peptic ulcers. This factor is bolstering the market growth rapidly.

Challenges

  • Increasing Alternative Drugs – Pantoprazole, lansoprazole, and esomeprazole are some of the alternative drugs of Omeprazole which are used widely around the world. Due to these alternatives in the market, the growth of the omeprazole market is expected to be hampered.
  • Side Effects of the Drug
  • Higher Cost of the Drug

Omeprazole Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

6.4%

Base Year Market Size (2023)

USD 1.06 Billion

Forecast Year Market Size (2036)

USD 2.38 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2477
  • Published Date: Jul 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of omeprazole is estimated at USD 1.12 Billion.

The omeprazole market size was valued at USD 1.06 Billion in 2023 and is expected to cross USD 2.38 Billion by the end of 2036, expanding at more than 6.4% CAGR during the forecast period i.e., between 2024-2036. Increasing cases of gastroesophageal reflux, increasing awareness among people, and increasing prevalence of duodenal ulcers.

Asia Pacific industry will hold a share of 28.6% by 2036, driven by greater awareness amongst target audiences about treating this condition, growing incidences, and intensified focus of key players to increase their product portfolio in the region.

Boehringer Ingelheim, AstraZeneca Plc., Azurity Pharma, Perrigo Company Plc., Salix pharmaceuticals
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample